162 related articles for article (PubMed ID: 21971459)
1. Research towards tau imaging.
Jensen JR; Cisek K; Funk KE; Naphade S; Schafer KN; Kuret J
J Alzheimers Dis; 2011; 26 Suppl 3():147-57. PubMed ID: 21971459
[TBL] [Abstract][Full Text] [Related]
2. Sporadic four-repeat tauopathy with frontotemporal lobar degeneration, Parkinsonism, and motor neuron disease: a distinct clinicopathological and biochemical disease entity.
Fu YJ; Nishihira Y; Kuroda S; Toyoshima Y; Ishihara T; Shinozaki M; Miyashita A; Piao YS; Tan CF; Tani T; Koike R; Iwanaga K; Tsujihata M; Onodera O; Kuwano R; Nishizawa M; Kakita A; Ikeuchi T; Takahashi H
Acta Neuropathol; 2010 Jul; 120(1):21-32. PubMed ID: 20140439
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease. Tangle disentanglement.
Beyreuther K; Masters CL
Nature; 1996 Oct; 383(6600):476-7. PubMed ID: 8849716
[No Abstract] [Full Text] [Related]
4. Biochemical and anatomical redistribution of tau protein in Alzheimer's disease.
Mukaetova-Ladinska EB; Harrington CR; Roth M; Wischik CM
Am J Pathol; 1993 Aug; 143(2):565-78. PubMed ID: 8342603
[TBL] [Abstract][Full Text] [Related]
5. [Alzheimer's disease: lesions and their progression].
Duyckaerts C; Colle MA; Delatour B; Hauw JJ
Rev Neurol (Paris); 1999; 155 Suppl 4():S17-27. PubMed ID: 10637934
[TBL] [Abstract][Full Text] [Related]
6. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.
Lewis J; Dickson DW; Lin WL; Chisholm L; Corral A; Jones G; Yen SH; Sahara N; Skipper L; Yager D; Eckman C; Hardy J; Hutton M; McGowan E
Science; 2001 Aug; 293(5534):1487-91. PubMed ID: 11520987
[TBL] [Abstract][Full Text] [Related]
7. [Neurofibrillary changes and phosphorylated tau of Alzheimer's disease].
Takeda M; Kudo T; Taniguchi N; Nishimura T
Nihon Ronen Igakkai Zasshi; 1996 Mar; 33(3):169-72. PubMed ID: 8648891
[No Abstract] [Full Text] [Related]
8. Truncated tau protein as a new marker for Alzheimer's disease.
Novák M
Acta Virol; 1994 Jun; 38(3):173-89. PubMed ID: 7817900
[TBL] [Abstract][Full Text] [Related]
9. Imaging as a strategy for premortem diagnosis and staging of tauopathies.
Kim S; Jensen JR; Cisek K; Funk KE; Naphade S; Schafer K; Kuret J
Curr Alzheimer Res; 2010 May; 7(3):230-4. PubMed ID: 20088805
[TBL] [Abstract][Full Text] [Related]
10. [Significance of tau in the development of Alzheimer's disease].
Takashima A
Brain Nerve; 2010 Jul; 62(7):701-8. PubMed ID: 20675874
[TBL] [Abstract][Full Text] [Related]
11. Biomedicine. Tauists and beta-aptists united--well almost!
Lee VM
Science; 2001 Aug; 293(5534):1446-7. PubMed ID: 11520974
[No Abstract] [Full Text] [Related]
12. Molecular dissection of the neurofibrillary lesions of Alzheimer's disease.
Goedert M
Arzneimittelforschung; 1995 Mar; 45(3A):403-9. PubMed ID: 7763334
[TBL] [Abstract][Full Text] [Related]
13. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.
Hardy J; Selkoe DJ
Science; 2002 Jul; 297(5580):353-6. PubMed ID: 12130773
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease. A new take on tau.
Marx J
Science; 2007 Jun; 316(5830):1416-7. PubMed ID: 17556561
[No Abstract] [Full Text] [Related]
15. Amyloid-beta, tau, and dementia.
Takashima A
J Alzheimers Dis; 2009; 17(4):729-36. PubMed ID: 19542626
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of Alzheimer's disease and dementia.
Bugiani O
Rev Neurol (Paris); 1999; 155 Suppl 4():S28-32. PubMed ID: 10637935
[TBL] [Abstract][Full Text] [Related]
17. Tau hyperphosphorylation in synaptosomes and neuroinflammation are associated with canine cognitive impairment.
Smolek T; Madari A; Farbakova J; Kandrac O; Jadhav S; Cente M; Brezovakova V; Novak M; Zilka N
J Comp Neurol; 2016 Mar; 524(4):874-95. PubMed ID: 26239295
[TBL] [Abstract][Full Text] [Related]
18. Fluorescent BODIPY-based Zn(II) complex as a molecular probe for selective detection of neurofibrillary tangles in the brains of Alzheimer's disease patients.
Ojida A; Sakamoto T; Inoue MA; Fujishima SH; Lippens G; Hamachi I
J Am Chem Soc; 2009 May; 131(18):6543-8. PubMed ID: 19368380
[TBL] [Abstract][Full Text] [Related]
19. [Tau, amyloid and Alzheimer's disease].
Olesen OF
Ugeskr Laeger; 1994 Feb; 156(8):1116-7, 1121-4. PubMed ID: 8116089
[TBL] [Abstract][Full Text] [Related]
20. Reversal by desferrioxamine of tau protein aggregates following two days of treatment in aluminum-induced neurofibrillary degeneration in rabbit: implications for clinical trials in Alzheimer's disease.
Savory J; Huang Y; Wills MR; Herman MM
Neurotoxicology; 1998 Apr; 19(2):209-14. PubMed ID: 9553957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]